Fecal Occult Blood Test Kit (Pirami Hole Method): Usage Guide
Fecal Occult Blood Test Kit (Pirami Hole Method): Usage Guide
Fecal Occult Blood Test Kit (Pirami hole method) is a rapid, immunochemical-based diagnostic reagent designed to detect trace amounts of human hemoglobin in fecal specimens using a standardized hole-punch sampling technique for reliable colorectal disease screening.
- Product SKU
- D1353067
- Detection Method
- Pirami hole method (immunochemical fecal occult blood test)
- Target Analyte
- Human hemoglobin in fecal specimens
- Sampling Technique
- Standardized hole-punch (Pirami) for consistent sample volume collection
- Application
- Colorectal cancer screening, gastrointestinal bleeding detection
- Specificity
- Human hemoglobin-specific; unaffected by dietary red meat (immunochemical principle)
Principle and Overview
The Fecal Occult Blood Test Kit (Pirami hole method) employs an immunochemical detection principle to identify human hemoglobin present in fecal samples at concentrations below the threshold of visual detection. Unlike older guaiac-based assays, this immunochemical fecal occult blood test (iFOBT) uses antibodies specific to human globin, thereby eliminating cross-reactivity with animal hemoglobin derived from dietary sources and reducing the need for pre-test dietary restrictions.
The Pirami hole method refers to a standardized sampling approach in which a purpose-designed hole-punch device collects a precise, reproducible volume of fecal material from the collection stick or card. This minimizes inter-operator variability in sample loading and is a key technical advantage over conventional smear-based collection methods.
The collected sample is suspended in a provided buffer solution and then applied to the immunochromatographic test strip or reaction zone, where any human hemoglobin present binds to labeled antibodies and produces a visible signal within the designated read time.
Materials Required and Kit Contents
Before beginning the assay, verify that all components are present and within their stated expiration date. Typical kit contents for the Pirami hole method include:
- Immunochromatographic test devices or strips – pre-coated with anti-human hemoglobin antibodies
- Sample collection tubes with buffer solution – used to dilute and homogenize the fecal specimen
- Pirami hole-punch sampling device – ensures a standardized, reproducible fecal sample volume
- Positive and negative controls – for assay validation on each run
- Package insert / Instructions for Use (IFU)
Additional laboratory materials required (not supplied): disposable gloves, a timer, and a flat clean work surface. Store the kit at the temperature specified on the product label; do not use reagents that have been frozen unless the IFU explicitly permits it.
Note: Confirm exact kit contents against the current product package insert (D1353067), as configurations may vary by lot.
Step-by-Step Protocol
Follow each step carefully and adhere to all safety precautions. Human fecal specimens are potentially biohazardous; handle with appropriate personal protective equipment throughout.
- Specimen collection: Using the provided collection stick, obtain a fecal sample from at least two different areas of the stool. Avoid contamination with urine, toilet water, or cleaning agents.
- Pirami hole-punch sampling: Insert the collection stick into the sample collection tube. Use the Pirami hole-punch device to punch through the fecal material adhering to the stick, allowing a standardized volume of sample to be released into the buffer solution in the tube. Cap the tube and mix thoroughly by inverting or vortexing gently for the time specified in the IFU.
- Equilibration: Allow the tube to stand at room temperature for the time stated in the IFU to ensure complete homogenization of the specimen in the buffer.
- Test device preparation: Remove the test device from its foil pouch immediately before use. Place it on a flat, horizontal surface.
- Sample application: Dispense the specified number of drops of the prepared sample suspension into the sample well of the test device, as directed by the IFU. Avoid introducing air bubbles.
- Incubation and reading: Start a timer immediately. Read results at the exact time window specified in the IFU (typically 5–10 minutes). Do not read results after the maximum reading time has elapsed, as this may yield inaccurate interpretations.
- Result interpretation: A visible line in both the control (C) and test (T) regions indicates a negative result. A visible line in the control (C) region only indicates a positive result. Absence of a control line indicates an invalid result; repeat the test with a new device.
- Waste disposal: Dispose of all used materials as biohazardous waste in accordance with local institutional and regulatory requirements.
Quality Control and Troubleshooting
Quality Control (QC): Run the provided positive and negative controls with each new lot of test kits and at the frequency required by your laboratory's QC policy. A valid positive control result confirms that the assay reagents are functional; a valid negative control result confirms the absence of carry-over contamination.
Common issues and corrective actions:
- Invalid result (no control line): Ensure the correct sample volume was added, that the buffer was properly prepared, and that the test device has not exceeded its expiration date. Repeat with a new device.
- Faint test line (weakly positive): Even a faint but visible test line should be considered positive according to standard immunochromatographic interpretation rules. Confirm with the IFU.
- Non-specific background staining: This may indicate improperly stored reagents or a degraded test device. Check storage conditions and lot expiration.
- Unexpected positive in negative control: Suspect cross-contamination of the control vial or buffer. Replace kit components and re-run.
Important limitations: This assay detects bleeding from the lower gastrointestinal tract more reliably than upper GI bleeding, as hemoglobin undergoes degradation during transit through the GI tract. A negative result does not exclude colorectal pathology. All positive results should prompt clinical follow-up.
Storage, Stability and Safety
Storage: Store the Fecal Occult Blood Test Kit (D1353067) at the temperature range specified on the product label and package insert. Do not freeze unless explicitly stated. Keep reagents away from direct sunlight, heat sources, and high humidity. Store individual pouches sealed until immediately before use to prevent moisture-induced degradation of the test membrane.
Stability: Use all kit components before the expiration date printed on the outer carton and individual pouches. Do not mix components from different lot numbers, as this may invalidate QC ranges and assay performance.
Safety: All fecal specimens and materials that have come into contact with them must be treated as potentially infectious. Wear disposable gloves, a laboratory coat, and eye protection when handling specimens. Wash hands thoroughly after completing the procedure. Dispose of all biological waste according to applicable biosafety regulations.
Review flag: Specific storage temperature range and shelf life should be confirmed against the current D1353067 package insert, as these parameters are not provided in the source material.
Frequently asked questions
What is the Pirami hole method and why is it used for fecal occult blood testing?
The Pirami hole method uses a standardized hole-punch device to collect a fixed, reproducible volume of fecal material from the collection stick into the buffer tube. This approach minimizes variability in sample amount between operators and collection events, improving the consistency and reliability of test results compared to conventional smear-based sampling techniques.
Do patients need to follow a special diet before providing a sample for this test?
Because this kit uses an immunochemical (antibody-based) detection method specific to human hemoglobin, it is generally not affected by dietary red meat or certain vegetables that can cause false positives in guaiac-based FOBT. However, clinicians should consult the product package insert (D1353067) and applicable clinical guidelines for any specific pre-collection instructions applicable to their setting.
What should I do if the control line does not appear in the test result window?
Absence of the control line indicates an invalid result regardless of whether the test line is visible. The test must be repeated using a new device from the same or a different lot. Check that the correct sample volume was dispensed, the buffer was not expired or improperly stored, and that the device was handled correctly before repeating the assay.
Can this kit detect bleeding from the stomach or small intestine?
Immunochemical FOBT kits are most sensitive for detecting colorectal (lower GI) bleeding. Blood from the upper gastrointestinal tract (stomach, small intestine) undergoes enzymatic and bacterial degradation during intestinal transit, which can reduce or destroy the human globin epitope recognized by the antibody, potentially leading to false-negative results. Upper GI bleeding is therefore better assessed by other diagnostic methods.
How should positive results be acted upon?
A positive fecal occult blood test result indicates the presence of human hemoglobin in the stool and should be followed up with appropriate clinical evaluation, such as colonoscopy, as recommended by the attending clinician and relevant clinical guidelines. A positive FOBT result alone is not diagnostic of colorectal cancer or any specific pathology.
References
- Aladdin Scientific. Fecal Occult Blood Test Kit (Pirami hole method) [Product D1353067]. Product package insert and documentation.
- Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Gastroenterol. 2002;97(10):2499-2507.
- Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462-1470.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证（带存储）